Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82423084 | 8242308 | 4 | F | 20110804 | 20160823 | 20111114 | 20160825 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-16222382 | BRISTOL MYERS SQUIBB | 0.00 | DY | F | Y | 3.34000 | KG | 20160825 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82423084 | 8242308 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Transplacental | 6 MG, QD | Y | 21436 | 6 | MG | TABLET | QD | |||||
| 82423084 | 8242308 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Transplacental | 3 MG, QD | Y | 21436 | 3 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 82423084 | 8242308 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 82423084 | 8242308 | OT |
| 82423084 | 8242308 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 82423084 | 8242308 | Congenital laryngeal stridor | |
| 82423084 | 8242308 | Foetal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 82423084 | 8242308 | 1 | 20101208 | 0 | ||
| 82423084 | 8242308 | 2 | 201106 | 20110804 | 0 |